Literature DB >> 16326135

Intrahepatic biliary epithelial cell damage and inflammation in portal tract in association with chronic colitis-harboring TCRalpha(-/-) mice.

Ikuko Haruta1, Etsuko Hashimoto, Yoichiro Kato, Hiroshi Miyakawa, Noriyuki Shibata, Makio Kobayashi, Keiko Shiratori.   

Abstract

BACKGROUND: Intrahepatic bile ducts are the target for inflammation in both primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC). The mechanisms of biliary epithelial cell damage in both diseases are not clearly understood. Ulcerative colitis (UC) is one of the known complications in PSC. In this study, we assessed the possible influence of apoptosis inhibitor expressed by macrophages (AIM) on intrahepatic bile ducts in the chronic colitis-harboring condition by generating T cell receptor alpha-deficient (TCRalpha(-/-))xAIM-deficient (AIM(-/-)) double-knockout mice.
METHODS: TCRalpha(-/-)xAIM(-/-) mice were generated by crossbreeding TCRalpha(-/-) mice with AIM(-/-) mice. At 24 weeks of age, mice were sacrificed to obtain liver tissues for pathological examinations, and blood was collected to study the serum levels of IgG, IgM and IgA.
RESULTS: In female TCRalpha(-/-)xAIM(-/-) mouse livers, mixed cellular infiltration in the portal area and epithelial cell damage in bile ducts were observed, when compared with female TCRalpha(-/-)xAIM(+/-) and male TCRalpha(-/-)xAIM(-/-) mice. Inflammation in hepatic parenchyma was mild to none in all mice. In the female mouse group, the serum IgA level was relatively increased in TCRalpha(-/-)xAIM(-/-) mice compared to TCRalpha(-/-)xAIM(+/-) mice.
CONCLUSION: The defect of AIM might be involved not only in colonic mucosal inflammation but also in portal inflammation, as well as in biliary epithelial cell damage in the livers of female TCRalpha(-/-)xAIM(-/-) mice.

Entities:  

Year:  2005        PMID: 16326135     DOI: 10.1016/j.hepres.2005.10.007

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  3 in total

1.  H3 histamine receptor agonist inhibits biliary growth of BDL rats by downregulation of the cAMP-dependent PKA/ERK1/2/ELK-1 pathway.

Authors:  Heather Francis; Antonio Franchitto; Yoshiyuki Ueno; Shannon Glaser; Sharon DeMorrow; Julie Venter; Eugenio Gaudio; Domenico Alvaro; Giammarco Fava; Marco Marzioni; Bradley Vaculin; Gianfranco Alpini
Journal:  Lab Invest       Date:  2007-03-05       Impact factor: 5.662

2.  Apoptosis inhibitor expressed by macrophages tempers autoimmune colitis and the risk of colitis-based carcinogenesis in TCRalpha-/- mice.

Authors:  Ikuko Haruta; Noriyuki Shibata; Yoichiro Kato; Masanori Tanaka; Makio Kobayashi; Hidetoshi Oguma; Keiko Shiratori
Journal:  J Clin Immunol       Date:  2007-07-06       Impact factor: 8.317

3.  Lipoteichoic acid may affect the pathogenesis of PBC-like bile duct damage and might be involved in systemic multifocal epithelial inflammations in chronic colitis-harboring TCRalpha-/-xAIM-/- mice.

Authors:  Ikuko Haruta; Etsuko Hashimoto; Noriyuki Shibata; Yoichiro Kato; Makio Kobayashi; Keiko Shiratori
Journal:  Autoimmunity       Date:  2007-07       Impact factor: 2.815

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.